HSPA14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.388600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.843400E-01
Normal-vs-Stage2
9.132600E-01
Normal-vs-Stage3
3.728000E-01
Normal-vs-Stage4
4.665000E-01
Stage1-vs-Stage2
7.963800E-01
Stage1-vs-Stage3
1.468630E-01
Stage1-vs-Stage4
4.997000E-01
Stage2-vs-Stage3
1.961390E-01
Stage2-vs-Stage4
3.492600E-01
Stage3-vs-Stage4
7.384200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.480000E-01
Normal-vs-AfricanAmerican
6.286200E-01
Normal-vs-Asian
9.591600E-01
Caucasian-vs-AfricanAmerican
4.372200E-01
Caucasian-vs-Asian
9.868000E-01
AfricanAmerican-vs-Asian
5.194800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.474800E-01
Normal-vs-Female
9.213000E-01
Male-vs-Female
8.633400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.813800E-01
Normal-vs-Age(41-60Yrs)
8.073200E-01
Normal-vs-Age(61-80Yrs)
9.851400E-01
Normal-vs-Age(81-100Yrs)
8.798200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.379800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.839000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.565000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.100600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.604800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.452400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.827800E-01
Normal-vs-Daily Drinker
8.589200E-01
Normal-vs-Weekly Drinker
7.366600E-01
Normal-vs-Occasional Drinker
8.619400E-01
Normal-vs-Social Drinker
7.376200E-01
Non Drinker-vs-Daily Drinker
7.530600E-01
Non Drinker-vs-Weekly Drinker
4.880400E-01
Non Drinker-vs-Occasional Drinker
7.268200E-01
Non Drinker-vs-Social Drinker
5.916400E-01
Daily Drinker-vs-Weekly Drinker
3.354400E-01
Daily Drinker-vs-Occasional Drinker
4.955600E-01
Daily Drinker-vs-Social Drinker
7.936200E-01
Weekly Drinker-vs-Occasional Drinker
6.724000E-01
Weekly Drinker-vs-Social Drinker
2.576200E-01
Occasional Drinker-vs-Social Drinker
3.467800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.730400E-01
Normal-vs-Grade 2
6.772800E-01
Normal-vs-Grade 3
2.933600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.233400E-01
Grade 1-vs-Grade 3
2.809600E-01
Grade 1-vs-Grade 4
7.730400E-01
Grade 2-vs-Grade 3
8.479000E-01
Grade 2-vs-Grade 4
6.772800E-01
Grade 3-vs-Grade 4
2.933600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.410200E-01
Normal-vs-NonDiabetic
9.904400E-01
Diabetic-vs-NonDiabetic
5.250000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.003600E-01
Normal-vs-NoPancreatitis
9.765400E-01
Pancreatitis-vs-NoPancreatitis
5.928000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.813800E-01
Normal-vs-N1
9.299800E-01
N0-vs-N1
8.692400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.549600E-01
Normal-vs-TP53-NonMutant
7.996600E-01
TP53-Mutant-vs-TP53-NonMutant
9.747700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
